Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesDurable Medical Equipment (DME)PacificSource Diabetic Equipment Coverage | OpenPa…
    Ask Trek AI about this page
    CurrentPacificSource Community SolutionsPolicy N/A

    Diabetic Equipment, Supplies, and Accessories

    Customize your policy alerts

    Sign up for all pacificsourcecommunitysolutions policy alerts

    Know when pacificsourcecommunitysolutions releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Coverage and medical-necessity criteria for blood glucose monitors, continuous glucose monitors, implantable glucose monitors, insulin pumps, diabetic supplies, and related professional services for applicable PacificSource members in Idaho, Montana, Oregon, and Washington.

    Policy Summary
    PayerPacificSource Community Solutions
    PolicyDiabetic Equipment, Supplies, and Accessories
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateApril 29, 2012
    Next Review DateJune 1, 2027
    Key ActionObtain prior authorization for therapeutic or implantable continuous glucose monitor coverage and submit the required medical-necessity documentation.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    4Applicable states
    3 yearsBGM replacement interval

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    5 yearsCGM receiver/transmitter replacement
    4/dayRequired pre-CGM testing

    Covered Equipment and Services

    Standard Blood Glucose Monitors

    Covered when ALL of the following are met:

    Standard blood glucose monitor

    • Diabetes diagnosis: The member has a diagnosis of Diabetes Mellitus.
    • Ability to use device: The member or responsible individual/caregiver is capable of using the device as prescribed.
    • Personal-use design: The device is designed for personal use.

    Specialty Blood Glucose Monitors

    Covered when ALL standard blood glucose monitor criteria and ONE specialty criterion are met:

    Specialty blood glucose monitor

    • Standard BGM criteria: The member has Diabetes Mellitus, the member or responsible individual/caregiver is capable of using the device as prescribed, and the device is designed for personal use.
    • ONE qualifying impairment

      • Severe visual impairment: The member has best corrected visual acuity of 20/200 or worse in both eyes and requires a special monitoring system (E2100).20/200 or worse in both eyes
      • Severe manual-dexterity impairment: The member has an impairment of manual dexterity severe enough to require a special monitoring system (E2101).Severe impairment

    Therapeutic Continuous Glucose Monitors

    Therapeutic CGM coverage is medically necessary when ALL of the following are met:

    Therapeutic continuous glucose monitor

    • Diabetes diagnosis: The member has a diagnosis of Diabetes Mellitus.
    • Insulin treatment: The member is currently receiving at least three subcutaneous insulin injections daily or uses an insulin pump.At least 3 SubQ injections daily or insulin pump
    • Prior blood glucose testing: Before CGM use, the member performs at least four blood glucose tests per day with a blood glucose monitoring device.At least 4 tests/day before CGM

    Implantable CGM Implantation

    Implantation is covered when ALL of the following are met:

    Implantable continuous glucose monitor implantation

    • Age: The member is 18 years of age or older.18 years or older
    • Diabetes diagnosis: The member has a diagnosis of Diabetes Mellitus.
    • Insulin treatment: The member is currently receiving at least three subcutaneous insulin injections daily or uses an insulin pump.At least 3 SubQ injections daily or insulin pump
    • Blood glucose testing:

    Implantable CGM Removal or Replacement

    Removal or replacement is covered when ANY ONE of the following is met:

    ONE qualifying condition

    • Device no longer needed: The member's device is no longer needed.
    • Sensor failure or expired lifespan: The member's sensor fails or the device lifespan has expired.

    Temporary use of continuous glucose monitors (CGMs) is not covered, including use during dialysis treatments or to obtain nutritional or blood-sugar information, because it is not considered medically necessary.

    Adjunctive (non-therapeutic) CGMs, transmitters, and sensors are not covered under medical benefit plans.

    Insulin and syringes are covered only under the prescription drug benefit. If the member does not have a prescription drug benefit, insulin and syringes are not coverable.

    Temporary CGM use during dialysis treatments or for nutritional or blood-sugar information is not medically necessary and is therefore not covered.

    Medical Necessity Requirements

    Continuous Glucose Monitor

    Therapeutic and implantable CGM coverage requires the applicable criteria below:

    Shared CGM medical-necessity criteria

    • Diabetes diagnosis: The member has a diagnosis of Diabetes Mellitus.
    • Insulin treatment: The member receives at least three subcutaneous insulin injections daily or uses an insulin pump.At least 3 SubQ injections daily or insulin pump
    • Blood glucose testing: The member performs at least four blood glucose tests per day with a blood glucose monitoring device.At least 4 tests/day

    Covered Codes and Allowances

    EquipmentHCPCSCovered
    E0607Home blood glucose Monitor
    E1399DME, miscellaneous
    E2100Blood glucose monitor w/integrated voice synthesizer
    E2101Blood glucose monitor with integrated lancing/blood sample
    E2102Adjunctive, nonimplanted continuous glucose monitor (CGM) or receiver
    E2103Non-adjunctive, nonimplanted continuous glucose monitor (CGM) or receiver
    Supplies and AccessoriesHCPCSCovered
    A4238Supply allowance for adjunctive, nonimplanted continuous glucose monitor (CGM), includes all supplies and accessories
    A4239Supply allowance for nonadjunctive, nonimplanted continuous glucose monitor (CGM), includes all supplies and accessories
    A4253Blood glucose test or reagent strips for home blood glucose monitor
    A4258Spring-powered device for lancet
    A9276Sensor; invasive (e.g., subcutaneous), disposable, for use with nondurable medical equipment interstitial continuous glucose monitoring system (CGM)
    A9277Transmitter; external, for use with nondurable medical equipment interstitial continuous glucose monitoring system (CGM)
    A9278Receiver (monitor); external, for use with nondurable medical equipment interstitial continuous glucose monitoring system
    Professional FeesmixedCovered
    95249Professional fee for patient-supplied equipment
    95250Professional fee for provider-supplied equipment
    95251Professional fee for device interrogation/interpretation
    0446TCreation of subcutaneous pocket with insertion of implantable interstitial glucose sensor, including system activation and patient training
    0447TRemoval of implantable interstitial glucose sensor from subcutaneous pocket via incision
    0448TRemoval of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new implantable sensor
    25For two of the above codes (95249, 95250, 95251) on the same date of service
    Home Blood Glucose Monitor
    CodeE0607 — Home blood glucose monitor
    Maximum units1 unit (each)
    FrequencyEvery 3 years/1095 days
    Specialty Blood Glucose Monitors
    CodesE2100 — Blood glucose monitor with integrated voice synthesizer; E2101 — blood glucose monitor with integrated lancing/blood sample
    Maximum units1 unit each
    Frequency

    Authorization and Coverage Actions

    Prior Authorization

    Prior Authorization Required for CGM

    Obtain prior authorization for CGM monitors, transmitters, and sensors billed under the medical benefit. Preferred therapeutic products are Freestyle Libre and Dexcom; these are generally administered under the Pharmacy benefit, with medical-benefit coverage by exception for Billings Clinic, City of Eugene, and Deschutes County.

    • Applicable codes: E2102, E2103, A4238, A4239, A9276, A9277, and A2978.
    • Confirm the member's benefit pathway and request authorization before dispensing or billing.
    Prior Authorization

    Prior Authorization Required for I-CGM

    Obtain prior authorization for implantable continuous glucose monitor services, including implantation, removal, and replacement procedures.

    • Applicable procedure codes: 0446T, 0447T, and 0448T.
    • Authorization should address the applicable medical-necessity criteria for implantation or for removal/replacement.

    Policy Background

    The policy supports diabetes screening and treatment through equipment and supplies used to monitor and maintain healthy blood glucose levels. Covered items include home blood glucose monitors, supplies, accessories, therapeutic CGMs, and implantable CGMs when applicable medical-necessity criteria are met. Maximum quantities and purchase frequencies for diabetic supplies are based on CMS guidance.

    Equipment and Monitor Definitions

    Blood Glucose Monitor
    Device typeStand-alone hand-held device
    Blood sampleThe member uses a lancet to obtain a blood sample
    Testing methodThe sample is placed on a test strip inserted into the hand-held device
    Insulin Pump (External)
    System typeBattery-operated system
    AdministrationAdministers continuous subcutaneous insulin through a subcutaneous needle or catheter
    Typical wear locationUsually worn about the waist

    Replacement Intervals

    E0607 Replacement
    CodeE0607 — Home blood glucose monitor
    Replacement intervalEvery 3 years
    Equivalent days1095 days
    E2100 Replacement
    CodeE2100 — Blood glucose monitor with integrated voice synthesizer
    Replacement intervalEvery 3 years
    Equivalent days1095 days

    Required Documentation

    Documentation Required

    Document specialty-monitor eligibility

    For E2100 or E2101, document severe bilateral visual impairment or severe manual-dexterity impairment requiring the special monitoring system, and obtain treating practitioner certification of the qualifying impairment.

    • For E2100, document best corrected visual acuity of 20/200 or worse in both eyes.
    • For E2101, document manual-dexterity impairment severe enough to require the special monitoring system.
    Documentation Required

    Support CGM medical necessity

    Submit medical-necessity documentation for therapeutic or implantable CGM requests. The record must establish the diabetes diagnosis, insulin regimen or pump use, blood glucose testing frequency, and frequent insulin-adjustment need.

    Documentation Required

    Excluded Services and Equipment

    The following are not covered under the medical benefit: temporary CGM use, including use during dialysis or for nutritional or blood-sugar information; adjunctive (non-therapeutic) CGMs, transmitters, and sensors; and insulin and syringes when the member does not have a prescription drug benefit. Insulin and syringes are covered only under the prescription drug benefit.

    Policy Summary
    PayerPacificSource Community Solutions
    PolicyDiabetic Equipment, Supplies, and Accessories
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateApril 29, 2012
    Next Review DateJune 1, 2027
    Key ActionObtain prior authorization for therapeutic or implantable continuous glucose monitor coverage and submit the required medical-necessity documentation.
    SourceLink
    On This Page
    Covered Equipment and ServicesMedical Necessity RequirementsCovered Codes and AllowancesAuthorization and Coverage ActionsPolicy BackgroundEquipment and Monitor DefinitionsReplacement IntervalsRequired DocumentationExcluded Services and Equipment
    Frequent insulin adjustment: The member requires frequent insulin adjustments based on blood glucose readings.Frequent adjustments
    The member performs at least four blood glucose tests per day with a blood glucose monitoring device.
    At least 4 tests/day
  1. Frequent insulin adjustment: The member requires frequent insulin adjustments based on blood glucose readings.Frequent adjustments
  2. Frequent insulin adjustment: The member requires frequent insulin adjustments based on blood glucose readings.Frequent adjustments
  3. Applicable device pathway

    • Therapeutic CGM: The request is for a therapeutic continuous glucose monitor, transmitter, or sensor.
    • Implantable CGM: The request is for implantation of an implantable continuous glucose monitor and the member is 18 years of age or older.18 years or older
  4. Every 3 years/1095 days
    Non-Adjunctive Nonimplanted CGM or Receiver
    CodeE2103 — Non-adjunctive, nonimplanted continuous glucose monitor (CGM) or receiver
    Maximum units1 unit (each)
    FrequencyEvery 5 years/1825 days
    CGM Supply Allowance
    CodesA4238 and A4239 — CGM supply allowances
    Maximum units3 units; 1 unit equals 1 month supply
    FrequencyEvery 3 months/90 days
    Blood Glucose Test Strips
    CodeA4253 — Blood glucose test or reagent strips for home blood glucose monitor
    Maximum units18 units; 1 unit equals 50 test strips
    FrequencyEvery 3 months/90 days
    Lancet Device
    CodeA4258 — Spring-powered device for lancet
    Maximum units2 units each
    FrequencyEvery 1 year/365 days
    CGM Sensor
    CodeA9276 — Invasive disposable CGM sensor
    Maximum units90 units; 1 unit equals 1 day
    FrequencyEvery 3 months/90 days
    CGM Transmitter
    CodeA9277 — External CGM transmitter
    Maximum units5 units each
    FrequencyEvery 5 years/1825 days
    CGM Receiver
    CodeA9278 — External CGM receiver
    Maximum units1 unit (each)
    FrequencyEvery 5 years/1825 days
    Billing Rule

    Pump and Cartridge Authorization

    Insulin infusion pumps do not require prior authorization. Insulin cartridges do require authorization through the Pharmacy benefit.

    • Bill the pump under the applicable DME benefit without prior authorization.
    • Route the insulin cartridge authorization through the Pharmacy benefit.
    Documentation Required

    Specialty BGM Certification

    Before ordering a specialty blood glucose monitor, the treating practitioner must certify that the member or caregiver has a qualifying severe visual or manual-dexterity impairment.

    • Severe visual impairment: best corrected visual acuity of 20/200 or worse in both eyes, requiring a special monitoring system (E2100).
    • Severe manual-dexterity impairment requiring a special monitoring system (E2101).
    • All standard blood glucose monitor coverage criteria must also be met.
    Documentation Required

    CGM Medical-Necessity Documentation

    Document the clinical information supporting CGM medical necessity before submitting the request. Therapeutic and implantable CGM requests must establish diabetes, the qualifying insulin regimen or pump use, frequent blood glucose testing, and the need for insulin adjustments.

    • Diagnosis of Diabetes Mellitus.
    • At least three daily subcutaneous insulin injections or use of an insulin pump.
    • At least four blood glucose tests per day with a blood glucose monitoring device before CGM use.
    • Need for frequent insulin adjustments based on blood glucose readings.
    • For I-CGM implantation, document that the member is age 18 or older.
    • Temporary CGM use, including use during dialysis or for nutritional/blood sugar information, is not medically necessary under the policy.
    Denial Risk

    EPSDT Review Required Before Denial

    For Oregon Medicaid EPSDT beneficiaries, complete an individual case-by-case review of medical necessity and medical appropriateness before denying coverage. Apply the applicable EPSDT requirements and relevant Oregon coverage guidance.

    • Relevant guidance may include HERC Guideline Note 108 and OAR 410-122-0520, 410-122-0525, and 410-122-0730.
    • Refer to the EPSDT policy for the required review process.
    Denial Risk

    CGM Criteria Not Met

    A therapeutic or implantable CGM request is at risk for denial when the applicable medical-necessity criteria are not met.

    • No documented Diabetes Mellitus diagnosis.
    • Insulin treatment is fewer than three daily subcutaneous injections and the member does not use an insulin pump.
    • Fewer than four blood glucose tests per day before CGM use, or testing is not documented.
    • No documented need for frequent insulin adjustments based on blood glucose readings.
    • For I-CGM implantation, the member is under age 18.
    • Temporary use, such as during dialysis or for nutritional/blood sugar information, is not covered as medically necessary.
    Denial Risk

    Adjunctive CGM Excluded from Medical Benefit

    Adjunctive, non-therapeutic CGMs, transmitters, and sensors are not covered under medical benefit plans.

    • Do not submit non-therapeutic CGM products as covered medical-benefit equipment.
    Billing Rule

    No Pharmacy Benefit

    Diabetic insulin and syringes are covered only under the prescription drug benefit. If the member does not have a prescription drug benefit, insulin and syringes are not coverable.

    • Receipts submitted for reimbursement process under the Pharmacy benefit.
    • Verify that the member has an active prescription drug benefit before dispensing or seeking reimbursement.
    Implantable Continuous Glucose Monitor
    SensorFluorescence-based sensor implanted subcutaneously
    ComponentsIncludes a smart transmitter and mobile application
    DisplayMobile application displays glucose values, trends, and alerts on a compatible mobile device
    Typical sensor lifespanUsually 90–180 days
    Non-Therapeutic (Adjunctive) Continuous Glucose Monitor
    Monitor typeNon-therapeutic (adjunctive) continuous glucose monitor
    Verification requirementRequires verification with a stand-alone home blood glucose monitor (BGM)
    TimingVerification is required before making treatment decisions
    Therapeutic (Non-Adjunctive) Continuous Glucose Monitor
    Monitor typeTherapeutic (non-adjunctive) continuous glucose monitor
    Treatment decisionsUsed to make treatment decisions without a stand-alone home blood glucose monitor (BGM)
    Confirmation requirementNo stand-alone BGM confirmation is needed to confirm testing results
    E2101 Replacement
    CodeE2101 — Blood glucose monitor with integrated lancing/blood sample
    Replacement intervalEvery 3 years
    Equivalent days1095 days
    E2103 Replacement
    CodeE2103 — Non-adjunctive, nonimplanted CGM or receiver
    Replacement intervalEvery 5 years
    Equivalent days1825 days
    A9277 Replacement
    CodeA9277 — External CGM transmitter
    Replacement intervalEvery 5 years
    Equivalent days1825 days
    A9278 Replacement
    CodeA9278 — External CGM receiver
    Replacement intervalEvery 5 years
    Equivalent days1825 days
    CGM Supply Allowance Replacement
    CodesA4238 and A4239 — CGM supply allowances
    Replacement or allowance intervalEvery 3 months
    Equivalent days90 days
    A4253 Replacement
    CodeA4253 — Blood glucose test or reagent strips
    Replacement or allowance intervalEvery 3 months
    Equivalent days90 days
    A4258 Replacement
    CodeA4258 — Spring-powered lancet device
    Replacement intervalEvery 1 year
    Equivalent days365 days
    A9276 Replacement
    CodeA9276 — Invasive disposable CGM sensor
    Replacement or allowance intervalEvery 3 months
    Equivalent days90 days

    Document EPSDT review before denial

    For EPSDT beneficiaries, conduct and document a case-by-case review of EPSDT medical necessity and medical appropriateness before denial.